Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng-Ru Shen

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Oncology|August 8, 2020
Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year ExperiencePei-Ying Wu, Ya-Min Cheng, Meng-Ru Shen, et al.
Journal of Cell Science|September 29, 2005
A rapid, nongenomic pathway facilitates the synaptic transmission induced by retinoic acid at the developing synapseJau-Cheng Liou, Shih-Yin Ho, Meng-Ru Shen, et al.
Human Genomics|March 6, 2023
Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancersChung-I Li, Yu-Min Yeh, Yi-Shan Tsai, et al.
Carcinogenesis|January 10, 2006
Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signalingMeng-Ru Shen, Yueh-Mei Hsu, Keng-Fu Hsu, et al.
Journal of Cell Science|February 5, 2013
The ER Ca²⁺ sensor STIM1 regulates actomyosin contractility of migratory cellsYing-Ting Chen, Yih-Fung Chen, Wen-Tai Chiu, et al.
Journal of Molecular Biology|June 24, 2008
Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic processYi-Ting Wang, Jian-Ying Chuang, Meng-Ru Shen, et al.
Scientific Reports|March 10, 2019
Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancerPeng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, et al.
Scientific Reports|November 16, 2019
Author Correction: STIM1-dependent Ca<sup>2+</sup> signaling regulates podosome formation to facilitate cancer cell invasionYun-Wen Chen, Chieh-Shan Lai, Yih-Fung Chen, et al.
Scientific Reports|July 18, 2020
Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancerPeng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, et al.
Scientific Reports|September 16, 2017
STIM1-dependent Ca<sup>2+</sup> signaling regulates podosome formation to facilitate cancer cell invasionYun-Wen Chen, Chieh-Shan Lai, Yih-Fung Chen, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|August 8, 2020
Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year ExperiencePei-Ying Wu, Ya-Min Cheng, Meng-Ru Shen, et al.
Journal of Cell Science|September 29, 2005
A rapid, nongenomic pathway facilitates the synaptic transmission induced by retinoic acid at the developing synapseJau-Cheng Liou, Shih-Yin Ho, Meng-Ru Shen, et al.
Human Genomics|March 6, 2023
Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancersChung-I Li, Yu-Min Yeh, Yi-Shan Tsai, et al.
Carcinogenesis|January 10, 2006
Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signalingMeng-Ru Shen, Yueh-Mei Hsu, Keng-Fu Hsu, et al.
Journal of Cell Science|February 5, 2013
The ER Ca²⁺ sensor STIM1 regulates actomyosin contractility of migratory cellsYing-Ting Chen, Yih-Fung Chen, Wen-Tai Chiu, et al.
Journal of Molecular Biology|June 24, 2008
Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic processYi-Ting Wang, Jian-Ying Chuang, Meng-Ru Shen, et al.
Scientific Reports|March 10, 2019
Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancerPeng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, et al.
Scientific Reports|November 16, 2019
Author Correction: STIM1-dependent Ca<sup>2+</sup> signaling regulates podosome formation to facilitate cancer cell invasionYun-Wen Chen, Chieh-Shan Lai, Yih-Fung Chen, et al.
Scientific Reports|July 18, 2020
Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancerPeng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, et al.
Scientific Reports|September 16, 2017
STIM1-dependent Ca<sup>2+</sup> signaling regulates podosome formation to facilitate cancer cell invasionYun-Wen Chen, Chieh-Shan Lai, Yih-Fung Chen, et al.
Pageof 11